2nd International Adalat® Symposium pp 251-257 | Cite as
Hemodynamic Study of Nifedipine Using Doppler Flowmetry
Chapter
Abstract
To study the effect of drugs on the cardiovascular system, pressure and flow must be measured simultaneously. Flow measurement usually requires venous and arterial puncture (for dye dilution) or use of costly equipment (isotope techniques). This study was initiated in order to introduce the use of a pulsed Doppler velocity meter for recording changes in aortic flow. The method was used for studying changes in hemodynamic parameters in resting, normal man after sublingual administration of 10 mg of Adalat.
Keywords
Stroke Volume Venous Return Total Peripheral Resistance Aortic Flow Ultrasonic Beam
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- 1.Angelsen, B. A. J., Aaslid, R., Brubakk, A.O.: Transcutaneous aortic blood velocity measurement by pulsed Doppler meter. Proc. III Nordic Meet. Med. and Biol. Eng., Tampere 1975.Google Scholar
- 2.van den Brand, M., Meester, G.T., Tiggelaar-de-Widt, L., deRuiter, R., Hugen-holtz, P.G.: Hemodynamic effect of nifedipine (Adalat) in patients catheterized for coronary artery disease. [Proc. II. International Adalat-symposium, Amsterdam, 1974.]Google Scholar
- 3.Bordley, J., III., Connor, C. A.R., Hamilton, W.F., Kerr, W.J., Wiggers, C.J.: Recommendation for human blood pressure determinations by sphygmomanometers. Circulation 4, 503–509 (1951).PubMedCrossRefGoogle Scholar
- 4.Fleckenstein, A., Tritthart, H., Döring, H. J., Byon, K. Y.: BAY a 1040 — ein hochaktiver Ca + +-antagonistischer Inhibitor der elektro-mechanischen Koppelungsprozesse im Warmblütermyokard. Arzneim.-Forsch. 22, 22–33 (1972).Google Scholar
- 5.Grün, G., Fleckenstein, A.: Die elektromechanische Entkoppelung der glatten Gefäßmuskulatur als Grundprinzip der Coronardilatation durch BAY a 1040, Nifedipine. Arzneim.-Forsch. (Drug Res.) 22, 334–344 (1972).Google Scholar
- 6.Hashimoto, K., Taira, N., Chiba, S., Hashimoto, K., Jr., Endoh, M., Kokubun, M., Kokubun, H., Iijima, T., Kimura, T., Kubota, K., Oguro, K.: Cardiohemodynamic effects of BAY a 1040 in the dog. Arzneim.-Forsch. 22, 15–21 (1972).Google Scholar
- 7.Kaltenbach, M., Becker, H. K., Kober, G., Loos, A.: Veränderungen der Hämodynamik des linken Herzen unter der Wirkung von Nifedipin (BAY a 1040) im Vergleich mit Nitroglycerin. Arzneim.-Forsch. 22, 362–365 (1972).Google Scholar
- 8.Kochsiek, K., Neubaum, J.: Die Wirkung von Nifedipin auf den Myokardstoffwechsel, die Hämodynamik, die Blutgase und den allgemeinen Stoffwechsel des Menschen. Arzneim.-Forsch. 22, 352–358 (1972).Google Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 1975